CA2375498A1 - Epithelial cell growth inhibitors - Google Patents

Epithelial cell growth inhibitors Download PDF

Info

Publication number
CA2375498A1
CA2375498A1 CA002375498A CA2375498A CA2375498A1 CA 2375498 A1 CA2375498 A1 CA 2375498A1 CA 002375498 A CA002375498 A CA 002375498A CA 2375498 A CA2375498 A CA 2375498A CA 2375498 A1 CA2375498 A1 CA 2375498A1
Authority
CA
Canada
Prior art keywords
protein
arg
xaa
ser
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002375498A
Other languages
English (en)
French (fr)
Inventor
Paul R. Ervin, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotherapies Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2375498A1 publication Critical patent/CA2375498A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002375498A 1999-06-18 2000-06-19 Epithelial cell growth inhibitors Abandoned CA2375498A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13999599P 1999-06-18 1999-06-18
US60/139,995 1999-06-18
PCT/US2000/016900 WO2000078955A1 (en) 1999-06-18 2000-06-19 Epithelial cell growth inhibitors

Publications (1)

Publication Number Publication Date
CA2375498A1 true CA2375498A1 (en) 2000-12-28

Family

ID=22489251

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002375498A Abandoned CA2375498A1 (en) 1999-06-18 2000-06-19 Epithelial cell growth inhibitors

Country Status (13)

Country Link
EP (1) EP1190054A1 (de)
JP (1) JP2003513615A (de)
KR (1) KR20020016837A (de)
CN (1) CN1399680A (de)
AU (1) AU783373B2 (de)
BR (1) BR0012301A (de)
CA (1) CA2375498A1 (de)
IL (1) IL147148A0 (de)
MX (1) MXPA01013242A (de)
NZ (1) NZ516545A (de)
PL (1) PL352997A1 (de)
WO (1) WO2000078955A1 (de)
ZA (1) ZA200200145B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500937B1 (en) 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
AU2000257514A1 (en) * 2000-06-19 2002-01-02 The University Of Michigan Mammastatin sequence variant c
CN102787094B (zh) * 2011-05-17 2015-09-23 李晖 培养基、细胞培养用试剂盒及细胞培养方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031625A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
WO1998014577A2 (en) * 1996-10-03 1998-04-09 Biotherapies, Inc. Nucleotide and protein sequence of mammastatin and methods of use
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor

Also Published As

Publication number Publication date
KR20020016837A (ko) 2002-03-06
AU6052300A (en) 2001-01-09
NZ516545A (en) 2004-06-25
IL147148A0 (en) 2002-08-14
MXPA01013242A (es) 2002-11-04
WO2000078955A1 (en) 2000-12-28
EP1190054A1 (de) 2002-03-27
JP2003513615A (ja) 2003-04-15
ZA200200145B (en) 2003-04-30
BR0012301A (pt) 2002-03-26
AU783373B2 (en) 2005-10-20
WO2000078955A9 (en) 2002-09-06
PL352997A1 (en) 2003-09-22
CN1399680A (zh) 2003-02-26

Similar Documents

Publication Publication Date Title
US9610330B2 (en) Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
DE60103052T2 (de) Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten
EP2213296B1 (de) Fgf1/fgf chimäres protein und verwendung
EP1068357A1 (de) Therapeutische und diagnostische anwendungen welche auf der rolle von cxcr-4 in der tumorgenese basieren
WO2006046239A2 (en) A thymus-specific protein
NZ266162A (en) Dna encoding grb3-3 capable of inducing cell death and its use in anti-cancer gene therapy
US11628206B2 (en) Method for inhibiting STAT3 activity comprising administering Ssu72
CN107629114B (zh) 多肽、其衍生物及其在制备抗肺纤维化的药物中的应用
AU783373B2 (en) Epithelial cell growth inhibitors
WO1998022505A1 (fr) Polypeptides solubles
JP2729712B2 (ja) 機能性ポリペプチド
DE3884853T2 (de) Angiogenininhibitoren.
US20030157576A1 (en) Epithelial cell growth inhibitors
JP2001527402A (ja) Ｎｇｆ変異体
KR100256664B1 (ko) 단백질 p140의 신규 폴리펩티드 및 그를 암호하는 dna
WO1999055380A1 (en) Nr-CAM GENE, NUCLEIC ACIDS AND NUCLEIC ACID PRODUCTS FOR THERAPEUTIC AND DIAGNOSTIC USES FOR TUMORS
EP1237910B1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
KR100885545B1 (ko) Ｒａｎｋ 저해 활성을 갖는 폴리펩티드, 그를 포함하는약학적 조성물, 그를 이용한 개체의 파골세포 분화를억제하는 방법 및 파골세포의 분화 및 활성화로 인하여야기되는 질병을 치료 또는 예방하는 방법, 그를 코딩하는핵산, 상기 핵산을 포함하는 벡터 및 숙주세포
WO2012150676A1 (ja) ２型ｔｎｆ受容体の発現を誘導する合成ペプチド及びその利用
US20020086017A1 (en) GA binding protein and neurite derived growth factors for use in the treatment of muscular dystrophy
KR20210154784A (ko) 섬유질환 예방 또는 치료용 재조합 융합 단백질
KR20120095063A (ko) ＩＬ-27로 유도된 ｐ53을 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
JPH05213771A (ja) ヘパリン結合性神経突起の成長プロモーター因子
WO2001019389A1 (fr) Remedes pour l'arthrite rhumatoide et proteine fusionnee

Legal Events

Date Code Title Description
FZDE Discontinued